Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 8, 1999

View Archived Issues

Lorus Therapeutics announces preclinical data on anticancer compound

Ilex Oncology focuses on anticancer drugs

Micrologix Biotech continues preclinical testing on acne drugs

Genelabs Technologies' DARPA drug discovery grant renewed

Gastric antisecretory and gastroprotective compounds in development at Byk Gulden

Merck researchers design tachykinin antagonists particularly useful as antiemetics

FDA awards fast track designation to Trimeris's HIV fusion inhibitor

Antiulcer benzimidazoles discovered by Dr. Reddy's group

Novartis describes new PNP inhibitor series in recent patent literature

Purinoceptor P2 receptor antagonists in early development at Astra

Second-generation NNRTIs show promising resistance profile, pharmacokinetics in preclinical studies

Orphan Medical's Busulfex Injection approved in U.S.

Ex vivo studies explain disappointing results with antiadhesion therapy in stroke patients

Boston Life Sciences identifies a second antiangiogenic molecule

Lubeluzole shows good safety but no efficacy in large trial in acute stroke patients

Sch-217048: potent and selective neurokinin antagonist from natural sources

Ligand receives FDA approval for Ontak as CTCL treatment

Preclinical profile of novel antimigraine agent SB-220453 described

Emadine approved for conjunctivitis in Europe

UCB files NDA for levetiracetam

Kitasato investigators discover new microbial-based compound for atherosclerosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...